Endymed Ltd (TLV: ENDY)
Israel
· Delayed Price · Currency is ILS · Price in ILA
310.00
+3.20 (1.04%)
Jan 19, 2025, 12:31 PM IDT
Endymed Revenue
Endymed had revenue of $4.44M USD in the quarter ending September 30, 2024, a decrease of -12.95%. This brings the company's revenue in the last twelve months to $18.94M, down -17.00% year-over-year. In the year 2023, Endymed had annual revenue of $22.78M with 6.77% growth.
Revenue (ttm)
$18.94M
Revenue Growth
-17.00%
P/S Ratio
0.60
Revenue / Employee
$411.80K
Employees
46
Market Cap
42.80M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.78M | 1.45M | 6.77% |
Dec 31, 2022 | 21.33M | -449.00K | -2.06% |
Dec 31, 2021 | 21.78M | 7.44M | 51.85% |
Dec 31, 2020 | 14.35M | -2.10M | -12.78% |
Dec 31, 2019 | 16.45M | -2.01M | -10.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 62.35B |
Danel (Adir Yeoshua) | 2.71B |
Kamada | 588.75M |
Bait Bakfar | 102.08M |
Novolog (Pharm-Up 1966) | 1.73B |
Ilex Medical | 982.96M |
BrainsWay | 143.60M |
SofWave Medical | 210.53M |